A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families

Am J Psychiatry. 2011 Aug;168(8):848-52. doi: 10.1176/appi.ajp.2011.10091319. Epub 2011 May 15.

Abstract

Objective: The authors tested for genetic linkage of DSM-IV-diagnosed major depressive disorder in families that were ascertained for cigarette smoking.

Method: Within a study that targeted families characterized by a history of smoking, analyses derived a subset of 91 Australian families with two or more offspring with a history of DSM-IV major depressive disorder (affected sibling pairs, N=187) and 25 Finnish families (affected sibling pairs, N=33). Within this affected sibling pairs design, the authors conducted nonparametric linkage analysis.

Results: In the Australian heavy smoking families, the authors found a genome-wide significant multipoint LOD score of 4.14 for major depressive disorder on chromosome 3 at 24.9 cM (3p26-3p25).

Conclusions: Genome-wide significant linkage was detected for major depressive disorder on chromosome 3p in a sample ascertained for smoking. A linkage peak at this location was also observed in an independent study of major depressive disorder.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Twin Study

MeSH terms

  • Adult
  • Alleles*
  • Chromosomes, Human, Pair 3 / genetics*
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / genetics*
  • Depressive Disorder, Major / psychology
  • Diagnostic and Statistical Manual of Mental Disorders*
  • Diseases in Twins / genetics*
  • Finland
  • Genetic Linkage / genetics*
  • Genome-Wide Association Study*
  • Genotype
  • Humans
  • Lod Score
  • Polymorphism, Single Nucleotide / genetics
  • Queensland
  • Receptors, Metabotropic Glutamate / genetics*
  • Smoking / genetics*
  • Smoking / psychology

Substances

  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 7

Grants and funding